Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Guangdong Association of Clinical Trials
Condition: Lung Cancer (Non-Small Cell)
NCT07198841
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.